Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)

OBJECTIVE: The goal of this work is to evaluate if there is an increase in the risk of thromboembolic events (TEEs) due to concomitant exposure to dexamethasone and apixaban or rivaroxaban. Direct oral anticoagulants (DOACs), as well as corticosteroid dexamethasone, are commonly used to treat indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kravchenko, Olga V, Boyce, Richard D, Gomez-Lumbreras, Ainhoa, Kocis, Paul T, Villa Zapata, Lorenzo, Tan, Malinda, Leonard, Charles E, Andersen, Kathleen M, Mehta, Hemalkumar, Alexander, G Caleb, Malone, Daniel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806069/
https://www.ncbi.nlm.nih.gov/pubmed/36581417
http://dx.doi.org/10.1136/bmjopen-2022-066846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806069/
https://www.ncbi.nlm.nih.gov/pubmed/36581417
http://dx.doi.org/10.1136/bmjopen-2022-066846

Ejemplares similares